Skip to main content Accessibility help
×
Home

Vitamin D and diabetes

In a nutshell

Vitamin D has protective associations with type 1 and type 2 diabetes, as well as metabolic syndrome.

RCTs for prevention or treatment are so far thin on the ground and not all had positive outcomes. If vitamin D does prove to have application for diabetes, dosage issues are likely to be critical.

Copyright

References

Hide All
1. Reis, AF. et al. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab. 2005 Sep;31(4 Pt 1):318–25.
2. Nagpal, S. et al. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005 Aug;26(5):662–87.
3. Harris, SS. Vitamin D in type 1 diabetes prevention. J Nutr. 2005 Feb;135(2):323–5.
4. Peechakara, SV. et al. Vitamin D as a potential modifier of diabetes risk. Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):182–3.
5. Pittas, AG. et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007 Jun;92(6):2017–29.
6. Bener, A. et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2008 Oct 10. [Epub ahead of print]
7. Knekt, P. et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008 Sep;19(5):666–71.
8. Zhang, C. et al. Maternal plasma 25-hydroxyvitamin d concentrations and the risk for gestational diabetes mellitus. PLoS ONE. 2008;3(11):e3753.
9. Reis, JP. et al. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol. 2008 Jul;159(1):41–8.
10. Rueda, S. et al. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg. 2008 Feb;18(2):151–4.
11. McGill, AT. et al. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008 Jan 28;7:4.
12. Hahn, S. et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):577–83.
13. Aksoy, H. et al. Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem. 2000 Feb;33(1):4751.
14. Targher, G. et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf). 2006 Nov;65(5):593–7.
15. Li, YC. Vitamin D and diabetic nephropathy. Curr Diab Rep. 2008 Dec;8(6):464–9.
16. Anon. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia. 1999 Jan;42(1):51–4.
17. Hyppönen, E. et al. Intake of vitamin D and risk of type 1 diabetes: a birthcohort study. Lancet. 2001 Nov 3;358(9292):1500–3.
18. Maestro, B. et al. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000 Aug;47(4):383–91.
19. Palomer, X. et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008 Mar;10(3):185–97.
20. Chertow, B. Advances in diabetes for the millennium: vitamins and oxidant stress in diabetes and its complications. MedGenMed. 2004 Nov 1;6(3 Suppl):4.
21. Adorini, L. et al. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008 Aug;4(8):404–12.
22. Danescu, LG. et al. Vitamin D and diabetes mellitus. Endocrine. 2008 Nov 1.
23. Giulietti, A. et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract. 2007 Jul;77(1):4757.
24. Arnson, Y. et al. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007 Sep;66(9):1137–42.
25. Ginanjar, E. et al. Vitamin D and autoimmune disease. Acta Med Indones. 2007 Jul-Sep;39(3):133–41.
26. Rammos, G. et al. Vitamin D, the renin-angiotensin system, and insulin resistance. Int Urol Nephrol. 2008;40(2):419–26.
27. Guo, SW. et al. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am J Epidemiol. 2006 Oct 15;164(8):711–24.
28. Boraska, V. et al. Family-based analysis of vitamin D receptor gene polymorphisms and type 1 diabetes in the population of South Croatia. J Hum Genet. 2008;53(3):210–4.
29. Mimbacas, A. et al. Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Genet Mol Res. 2007 Sep 5;6(3):534–42.
30. Shimada, A. et al. Japanese Study Group on Type 1 Diabetes Genetics. Evidence for association between vitamin D receptor BsmI polymorphism and type 1diabetes in Japanese. J Autoimmun. 2008 Jun;30(4):207–11.
31. Bailey, R. et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes. 2007 Oct;56(10):2616–21.
32. Ramos-Lopez, E. et al. Protection from type 1 diabetes by vitamin D receptor haplotypes. Ann N Y Acad Sci. 2006 Oct;1079:327–34.
33. Ortlepp, JR. et al. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med. 2001 Oct;18(10):842–5.
34. Speer, G. et al. Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol. 2001 Apr;144(4):385–9.
35. Ye, WZ. et al. Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians. Metabolism. 2001 Mar;50(3):366–9.
36. Ye, WZ. et al. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol. 2001 Aug;145(2):181–6.
37. Holick, MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004 Mar;79(3):362–71.
38. Calvo, MS. et al. Vitamin D intake: a global perspective of current status. J Nutr. 2005 Feb;135(2):310–6.
39. Wicklow, BA. et al. Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk. Ann N Y Acad Sci. 2006 Oct;1079:310–2.
40. Inomata, S. et al. Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner. 1986 Jun;1(3):187–92.
41. Lind, L. et al. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure.
42. Orwoll, E. et al. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994 May;59(5):1083–7.
43. Borissova, AM. et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003 May;57(4):258–61.
44. Pittas, AG. et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007 Apr;30(4):980–6.
45. Morris, HA. Vitamin D: a hormone for all seasons--how much is enough? Clin Biochem Rev. 2005 Feb;26(1):2132.
46. Pittas, AG. et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006 Mar;29(3):650–6.

Related content

Powered by UNSILO

Vitamin D and diabetes

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.